Company Filing History:
Years Active: 2011
Title: Csaba Tomboly: Innovator of Isotopically Marked Quinoline Derivatives
Introduction
Csaba Tomboly is a notable inventor based in Szeged, Hungary, with a significant contribution to the field of medicinal chemistry. He has developed innovative compounds that have implications for pharmacology and molecular biology.
Latest Patents
Tomboly holds a patent for "Isotopically marked quinoline derivatives as adenosin A3 receptor ligands." This invention pertains to adenosin A3 receptor ligands labeled with iodine isotopes of mass number 125. His work focuses particularly on favorably antagonistic compounds and their isomers, providing valuable insights into their experimental applications. The patent describes a comprehensive process for the preparation of these compounds, along with new intermediates essential for their synthesis.
Career Highlights
Csaba Tomboly is currently affiliated with Sanofi-Aventis, a leading global pharmaceutical company. His role allows him to engage in cutting-edge research and development of pharmaceutical compounds, contributing to significant advancements in medicine.
Collaborations
Throughout his career, Tomboly has collaborated with talented professionals such as Geza Timari and Kinga Boer. Collaboration in such a dynamic environment fosters innovation and accelerates the development of new therapeutic agents.
Conclusion
Csaba Tomboly exemplifies dedication to innovation in the field of medicinal chemistry. His work on isotopically marked quinoline derivatives expands the frontiers of pharmaceutical research, potentially leading to new therapeutic treatments. As advancements in this area continue, the significance of his contributions to the scientific community will undoubtedly grow.